A highly sensitive strategy for glypican-3 detection based on aptamer/gold carbon dots/magnetic graphene oxide nanosheets as fluorescent biosensor
- 5 July 2022
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 414 (22) , 6441-6453
Abstract
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths in China. Glypican-3 (GPC3) is a specific antigen related to HCC, which is widely used in clinical detection as a reliable marker of HCC. In this paper, a highly sensitive homogeneous apatasensor was designed for GPC3 detection based on fluorescence resonance energy transfer (FRET) where the GPC3 aptamer labelled gold carbon dots (AuCDs-GPC3Apt) are used as a donor and magnetic graphene oxide (Fe3O4/GO) nanosheets are used as an acceptor. A one-step hydrothermal method was used to synthesize AuCDs to provide sufficient fluorescence. The FRET phenomenon exists between AuCDs-GPC3Apt and Fe3O4/GO, which weakens the fluorescence intensity of the whole system. When the target GPC3 is added to the FRET system, the fluorescent AuCDs-GPC3Apt binds to the GPC3 and forms a folded structure, which leads to AuCDs-GPC3Apt separation from Fe3O4/GO nanosheets. The Fe3O4/GO is then magnetically separated so that the fluorescence of free labelled AuCDs-GPC3Apt is restored. Under the optimum conditions, the fluorescence recovery rate is linearly correlated with the concentration of GPC3 (5–100 ng·mL−1) and the detection limit is 3.01 ng·mL−1 (S/N = 3). This strategy shows recoveries from 98.76 to 101.29% in real human serum samples and provides an immediate and effective detection method for the quantification of GPC3 with great potential applications for early diagnosis of HCC. Graphical abstract A sensitive homogeneous FRET-based apatasensor was designed for GPC3 detection where the AuCDs-GPC3Apt is a donor and Fe3O4/GO nanosheets are an acceptor. The GPC3 fluorescent aptasensor combines wider output range with low cost, high specificity, and good anti-interference.Keywords
Funding Information
- Open Fund of Guangxi Key Laboratory of Bio-targeting Theranostics (Nos. GXSWBX201902, GXSWBX201903)
- National Nature Science Foundation of China (Nos. 81760534, 82073607)
This publication has 49 references indexed in Scilit:
- Magnetic separate "turn-on" fluorescent biosensor for Bisphenol A based on magnetic oxidation grapheneTalanta, 2017
- Can glypican‐3 be a disease‐specific biomarker?Clinical and Translational Medicine, 2017
- Material chemistry of graphene oxide-based nanocomposites for theranostic nanomedicineJournal of Materials Chemistry B, 2017
- Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3Journal of Fluorescence, 2017
- Fluorescence Resonance Energy Transfer-Based DNA Tetrahedron Nanotweezer for Highly Reliable Detection of Tumor-Related mRNA in Living CellsACS Nano, 2017
- Study on a new high affinity anti-glypicans-3 antibody in diagnosis of early hepatocellular carcinoma by differential pulse voltammetryJournal of Solid State Electrochemistry, 2017
- Selective Visualization of the Endogenous Peroxynitrite in an Inflamed Mouse Model by a Mitochondria-Targetable Two-Photon Ratiometric Fluorescent ProbeJournal of the American Chemical Society, 2016
- Functionalization of Graphene Oxide and its Biomedical ApplicationsCritical Reviews in Solid State and Materials Sciences, 2015
- Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesisNature Communications, 2015
- An XPS study of Au alloyed Al–O sputtered coatingsApplied Surface Science, 2011